Zacks Small Cap Weighs in on MGRM Q3 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Stock analysts at Zacks Small Cap issued their Q3 2025 EPS estimates for Monogram Orthopaedics in a research note issued to investors on Thursday, March 13th. Zacks Small Cap analyst T. Kerr forecasts that the company will earn ($0.11) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share.

A number of other equities analysts also recently commented on the stock. Roth Capital raised shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th. Roth Mkm assumed coverage on shares of Monogram Orthopaedics in a research report on Monday, December 9th. They issued a “buy” rating and a $4.00 price target on the stock.

Monogram Orthopaedics Trading Up 0.9 %

Shares of MGRM opened at $2.33 on Friday. Monogram Orthopaedics has a 52 week low of $1.53 and a 52 week high of $4.90. The firm has a market cap of $79.95 million, a price-to-earnings ratio of -4.96 and a beta of 1.66. The stock has a 50 day moving average of $2.54 and a 200-day moving average of $2.49.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03.

Hedge Funds Weigh In On Monogram Orthopaedics

Several institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its position in Monogram Orthopaedics by 1,267.4% during the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after purchasing an additional 194,776 shares during the period. Fiduciary Family Office LLC bought a new stake in Monogram Orthopaedics in the fourth quarter valued at $70,000. Northern Trust Corp boosted its holdings in shares of Monogram Orthopaedics by 110.6% during the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock valued at $109,000 after acquiring an additional 24,088 shares during the period. State Street Corp bought a new position in shares of Monogram Orthopaedics during the third quarter worth about $62,000. Finally, Orion Portfolio Solutions LLC acquired a new stake in shares of Monogram Orthopaedics in the 4th quarter worth about $31,000. 0.45% of the stock is owned by institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.